Chargement en cours...
Induction of CD4(+) T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells
Dendritic cell–based (DC-based) immunotherapy represents a promising approach to the prevention and treatment of many diseases, including cancer, but current strategies have met with only limited success in clinical and preclinical studies. Previous studies have demonstrated that a TAT peptide deriv...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Clinical Investigation
2002
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC151000/ https://ncbi.nlm.nih.gov/pubmed/12045260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI15399 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|